Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases

The management of breast cancer brain metastases (BCBM) has historically involved local therapies. However, as novel systemic treatments have become more effective in controlling visceral disease, BCBM have also been better controlled. Immune checkpoint inhibitors (ICIs) have demonstrated efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlam, Ilana, Gatti-Mays, Margaret E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256020/
https://www.ncbi.nlm.nih.gov/pubmed/35598254
http://dx.doi.org/10.1093/oncolo/oyac064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256020/
https://www.ncbi.nlm.nih.gov/pubmed/35598254
http://dx.doi.org/10.1093/oncolo/oyac064

Ejemplares similares